News
Hosted on MSN2mon
Passage Bio CFO sells shares worth $1,685Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company currently valued at $32.66 million, recently executed a series of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback